Clinical Trial Update: A Single and Repeated Dose Escalation of RBD1016 in Subjects with Chronic Hepatitis B Virus (HBV) Infection [Phase 1]

View source ↗

Summary

This document provides a Phase 1 trial update on the single and repeated dose escalation of RBD1016 in subjects with chronic hepatitis B. The study status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• RBD1016 (RBD1016)

Snippet

Sponsor: Suzhou Ribo Life Science Co. Ltd. | Conditions: Chronic Hepatitis B | Phase 1 | Status: COMPLETED